Chemical Abortion Risk Awareness Act

This bill requires providers receiving federal funds to provide detailed, FDA-approved drug warnings about chemical abortions to patients at least 24 hours before the procedure. It mandates that providers highlight warnings and adverse reactions from the drug label, read them to patients, and obtain written confirmation. Non-compliant providers risk losing federal funding, and patients can sue for damages if providers fail to follow these requirements. The law specifically excludes medical emergencies like ectopic pregnancies or miscarriage treatment from its definition of "chemical abortion."